Correction: Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study.
[This corrects the article DOI: 10.1371/journal.pone.0238723.].
Guardado en:
Autores principales: | Yoshiki Ishibashi, Rie Nishitani, Akiyoshi Shimura, Ayano Takeuchi, Mamoru Touko, Takashi Kato, Sahoko Chiba, Keiko Ashidate, Nobuo Ishiwata, Tomoyasu Ichijo, Masataka Sasabe |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5309c878c2844a3f99b3945fd9d1896a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study.
por: Yoshiki Ishibashi, et al.
Publicado: (2020) -
Correction: Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study
por: Yoshiki Ishibashi, et al.
Publicado: (2021) -
Suvorexant: a promising, novel treatment for insomnia
por: Lee-Iannotti JK, et al.
Publicado: (2016) -
Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant
por: Norman JL, et al.
Publicado: (2016) -
Decongestant use and the risk of myocardial infarction and stroke: a case-crossover study
por: Lamiae Grimaldi-Bensouda, et al.
Publicado: (2021)